Spectral AI, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US84757T1051
USD
1.47
0.05 (3.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

290.69 k

Shareholding (Mar 2025)

FII

3.17%

Held by 10 FIIs

DII

89.13%

Held by 4 DIIs

Promoter

4.23%

How big is Spectral AI, Inc.?

22-Jun-2025

As of Jun 18, Spectral AI, Inc. has a market capitalization of 51.49 million, with net sales of 29.96 million and a net profit of -9.20 million over the last four quarters. Shareholder's funds are -7.25 million, and total assets are 12.10 million.

As of Jun 18, Spectral AI, Inc. has a market capitalization of 51.49 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 29.96 million, while the sum of net profit for the same period is -9.20 million.<BR><BR>As of Dec 24, the shareholder's funds are reported at -7.25 million, and total assets amount to 12.10 million.

Read More

What does Spectral AI, Inc. do?

22-Jun-2025

Spectral AI, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $7 million and a net profit of $3 million. It has a market cap of $51.49 million and a return on equity of 545.69%.

Overview:<BR>Spectral AI, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 7 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 3 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 51.49 Million (Micro Cap)<BR><BR>Key Metrics:<BR>Debt Equity: 3.59 <BR>Return on Equity: 545.69% <BR>Price to Book: -31.67<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Should I buy, sell or hold Spectral AI, Inc.?

22-Jun-2025

Is Spectral AI, Inc. overvalued or undervalued?

20-Sep-2025

As of November 14, 2023, Spectral AI, Inc. is considered risky and overvalued due to negative valuation ratios and underperformance compared to peers, despite a strong one-year return of 88.89% that contrasts with its year-to-date decline of 21.91%.

As of 14 November 2023, the valuation grade for Spectral AI, Inc. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its negative valuation ratios, including an EV to EBITDA of -9.34 and an EV to Sales ratio of 1.52, which suggest that the market may be pricing in more value than the company currently possesses. Additionally, the Price to Book Value stands at -31.67, further emphasizing the financial challenges faced by the company.<BR><BR>In comparison to its peers, Spectral AI, Inc. has a less favorable EV to EBITDA ratio than Verb Technology Co., Inc. at -49.7264 and Eightco Holdings, Inc. at -45.0204, highlighting its relative underperformance. The company's recent stock performance shows a 1-year return of 88.89%, significantly outperforming the S&P 500's 17.14%, but its year-to-date return of -21.91% contrasts sharply with the S&P 500's 12.22%, suggesting volatility and potential investor concerns. Overall, Spectral AI, Inc. is currently overvalued based on its financial metrics and peer comparisons.

Read More

Is Spectral AI, Inc. technically bullish or bearish?

20-Sep-2025

As of August 11, 2025, Spectral AI, Inc. has a mildly bullish trend, supported by daily moving averages and Bollinger Bands, but tempered by weekly bearish signals, with recent performance showing strong returns over the past year despite underperforming year-to-date.

As of 11 August 2025, the technical trend for Spectral AI, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages indicating mild bullishness, while the weekly MACD and KST show a mildly bearish signal. Bollinger Bands are bullish on both weekly and monthly time frames. However, the overall strength is tempered by the weekly OBV and Dow Theory, both indicating mild bearishness. <BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 11.06% and 4.25% respectively, while it has significantly underperformed year-to-date with a return of -21.91% compared to the S&P 500's 12.22%. Over the past year, the stock has shown strong performance with an 88.89% return, contrasting with the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -73.82% and Operating profit at -232.08% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.51
2

Negative results in Jun 25

3

Risky - Negative EBITDA

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 50 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.24

stock-summary
Return on Equity

89.25%

stock-summary
Price to Book

-5.46

Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Jun 2025)
Net Profit:
-8 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-33.48%
0%
-33.48%
6 Months
-30.0%
0%
-30.0%
1 Year
-17.42%
0%
-17.42%
2 Years
-45.76%
0%
-45.76%
3 Years
-85.31%
0%
-85.31%
4 Years
-85.02%
0%
-85.02%
5 Years
0%
0%
0.0%

Spectral AI, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-73.82%
EBIT Growth (5y)
-232.08%
EBIT to Interest (avg)
-3.51
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
3.59
Sales to Capital Employed (avg)
-1.70
Tax Ratio
3.60%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
19.89%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-31.67
EV to EBIT
-8.56
EV to EBITDA
-9.34
EV to Capital Employed
-6.12
EV to Sales
1.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 4 Schemes (3.46%)

Foreign Institutions

Held by 10 Foreign Institutions (3.17%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -23.88% vs -11.84% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -375.86% vs 137.66% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.10",
          "val2": "6.70",
          "chgp": "-23.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.00",
          "val2": "-0.80",
          "chgp": "-150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.60",
          "chgp": "-83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.40",
          "val2": "4.50",
          "chgp": "-220.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.00",
          "val2": "2.90",
          "chgp": "-375.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-419.20%",
          "val2": "-133.60%",
          "chgp": "-28.56%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 63.54% vs -28.74% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 26.79% vs -620.69% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29.60",
          "val2": "18.10",
          "chgp": "63.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.00",
          "val2": "-12.30",
          "chgp": "51.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.50",
          "val2": "-8.00",
          "chgp": "31.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-15.30",
          "val2": "-20.90",
          "chgp": "26.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-222.50%",
          "val2": "-719.10%",
          "chgp": "49.66%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
5.10
6.70
-23.88%
Operating Profit (PBDIT) excl Other Income
-2.00
-0.80
-150.00%
Interest
0.10
0.60
-83.33%
Exceptional Items
-5.40
4.50
-220.00%
Consolidate Net Profit
-8.00
2.90
-375.86%
Operating Profit Margin (Excl OI)
-419.20%
-133.60%
-28.56%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -23.88% vs -11.84% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -375.86% vs 137.66% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
29.60
18.10
63.54%
Operating Profit (PBDIT) excl Other Income
-6.00
-12.30
51.22%
Interest
3.00
0.00
Exceptional Items
-5.50
-8.00
31.25%
Consolidate Net Profit
-15.30
-20.90
26.79%
Operating Profit Margin (Excl OI)
-222.50%
-719.10%
49.66%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 63.54% vs -28.74% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 26.79% vs -620.69% in Dec 2023

stock-summaryCompany CV
About Spectral AI, Inc. stock-summary
stock-summary
Spectral AI, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available